Cargando…
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
A critical requirement in neuroendocrine tumor (NET) management is a blood biomarker test that is sensitive, specific and reproducible. We evaluated a PCR-based 51-transcript signature to detect tumors, compared it with chromogranin A (CgA) and examined the confounding effect of proton pump inhibito...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473957/ https://www.ncbi.nlm.nih.gov/pubmed/25316294 http://dx.doi.org/10.1530/EC-14-0100 |